Microbial yield from physiotherapy assisted sputum production in respiratory outpatients

BMC Pulmonary Medicine

Volumn 16, Issue 1, 2016, Pages

  Langridge, Philip J ^a   Sheehan, Reyenna L ^a   Denning, David W ^a,b  

^a MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Aspergillus; Hypertonic; Induced; Physiotherapy; Sputum

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL; SHORT ACTING DRUG; SODIUM CHLORIDE;

ACTIVE CYCLE OF BREATHING TECHNIQUE; ADULT; ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; ASTHMA; BACTERIUM CULTURE; BREATHING MECHANICS; BRONCHITIS; BRONCHOSPASM; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; CHRONIC PULMONARY ASPERGILLOSIS; CITROBACTER KOSERI; CLAVISPORA LUSITANIAE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FUNGUS CULTURE; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS PARAINFLUENZAE; HUMAN; INVASIVE ASPERGILLOSIS; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; MORAXELLA CATARRHALIS; MYCOBACTERIUM INTRACELLULARE; NEBULIZER; NONHUMAN; OUTPATIENT; PERICARDITIS; PHYSIOTHERAPY; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; SERRATIA MARCESCENS; SEVERE ASTHMA WITH FUNGAL SENSITIZATION; SINUSITIS; SPUTUM ANALYSIS; SPUTUM EXAMINATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; AGED; AMBULATORY CARE; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; COMPLICATION; FEMALE; GENETICS; HAEMOPHILUS INFECTIONS; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MYCETOMA; PSEUDOMONAS INFECTIONS; PULMONARY ASPERGILLOSIS; RESPIRATORY CARE; RESPIRATORY HYPERSENSITIVITY; SPUTUM; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; FEMALE; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MIDDLE AGED; MYCETOMA; PHYSICAL THERAPY MODALITIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY ASPERGILLOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY THERAPY; RESPIRATORY TRACT DISEASES; SALINE SOLUTION, HYPERTONIC; SPUTUM; YOUNG ADULT;

EID: 84956808633     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/s12890-016-0188-2     Document Type: Article

References (27)

1. Leigh TR, Hume C, Gazzard B, et al. Sputum induction for diagnosis of Pneumocystis carinii pneumonia. Lancet. 1989;2:205-6.
2. Wark PAB, Saltos N, Simpson J, Slater S, Hensley MJ, Gibson PG. Induced sputum eosinophils and neutrophils and bronchiectasis severity in allergic bronchopulmonary aspergillosis. Eur Respir J. 2000;16:1095-101.
3. Denning DW, Park S, Lass-Florl C, Fraczek MG, Kirwan M, Gore R, et al. High frequency triazole resistance found in non-culturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis. 2011;52:1123-9.
4. Fraczek MG, Kirwan MB, Moore CB, Morris J, Denning DW, Richardson MD. Volume dependency for culture of fungi from respiratory secretions and increased sensitivity of Aspergillus quantitative PCR. Mycoses. 2014;57:69-78.
5. Pashley CH, Fairs A, Morley JP, Tailor S, Agbetile J, Bafadhel M, et al. Routine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence. Med Mycol. 2012;50:433-8.
6. Makris D, Tzanakis N, Moschandreas J, et al. Dyspnea assessment and adverse events during sputum induction in COPD. BMC Pulm Med. 2006;6:1-9.
7. Fahey JV, Boushey HA, Lazarus SC, et al. Safety and reproducibility of sputum induction in asthmatic subjects in a multicenter study. Am J Respir Crit Care Med. 2001;163:1470-5.
8. Smith N, Denning DW. Underlying pulmonary disease frequency in patients with chronic pulmonary aspergillosis. Eur Resp J. 2011;37:865-72.
9. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature and review. Clin Infect Dis. 2003;37 Suppl 3:S265-80.
10. Agarwal R, Chakrabarti A, Shah A, et al. Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria. Clin Exp Allergy. 2013;43:850-73.
11. Denning DW, O'Driscoll BR, Powell G, et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitisation (SAFS), the FAST study. Am J Resp Crit Care Med. 2009;179:11-8.
12. Denning DW, Pashley C, Hartl D, et al. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14. doi: 10.1186/2045-7022-4-14. Published online 2014 April 15.
13. Chrdle A, Mustakim S, Bright-Thomas R, Baxter C, Felton T, Denning DW. Aspergillus bronchitis in non-immunocompromised patients - case series, response to treatment and criteria for diagnosis. Ann NY Acad Sci. 2012;1272:73-85.
14. UK standards for microbiological investigations: Investigation of bronchoalveolar sputum and associated specimens. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/343994/B_57i2.5.pdf (Accessed 15th August 2015).
15. Bueid A, Howard SJ, Moore CB, et al. Azole antifungal resistance in Aspergillus fumigatus - 2008 and 2009. J Antimicob Chemother. 2010;65:2116-8.
16. Suri R, Marshall LJ, Wallis C, et al. Safety and use of sputum induction in children with cystic fibrosis. Pediatr Pulmonol. 2003;35:309-13.
17. Lewis White P, Barnes RA. Aspergillus PCR. Platforms, strengths and weaknesses. Med Mycol. 2006;44:S191-8.
18. Bretagne S, Costa JM, Marmarot-Khuong A, et al. Detection of Aspergillus species DNA in bronchoalveolar lavage samples by competitive PCR. J Clin Microbiol. 1995;33:1164-8.
19. Kosmidis C, Denning DW. The clinical spectrum of pulmonary aspergillosis. Thorax. 2015;70:270-7.
20. Harris JR, Marston BJ, Sangrujee N, DuPlessis D, Park B. Cost-effectiveness analysis of diagnostic options for Pneumocystis Pneumonia (PCP). PLoS ONE. 2001;6:e23158.
21. Pasteur MC, Bilton D, Hill AT. British Thoracic Society guideline for non-CF bronchiectasis. Thorax. 2010;65:i1-58.
22. Elkins MR, Lane T, Goldberg H, et al. Effect of airway clearance techniques on the efficacy of the sputum induction procedure. Eur Respir J. 2005;26:904-8.
23. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, et al. Sputum induction. Eur Respir J. 2002;37(Suppl):3s-8s.
24. Pizzichini MMM, Leigh R, Djukanovic R, Sterk PJ. Safety of sputum induction. Eur Respir J. 2002;27(Suppl):9s-18s.
25. Elkins M. Sputum induction - current practice in Australia & New Zealand. Respirology. 2003;7(Suppl):1-A63.
26. Khatri L, Taylor KMG, Craig DQM, Palin K. An assessment of jet and ultrasonic nebulisers for the delivery of lactate dehydrogenase solutions. Int J Pharm. 2001;227:121-31.
27. Hess D, Fisher D, Williams P, Pooler S, Kacmarek RM. Medication nebulizer performance- effects of diluent volume, nebulizer flow and nebulizer brand. Chest. 1996;110:498-505.